[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341922-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341922-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","systematic-review-and-meta-analysis-meta-analysis-of-fto-expression-on-the-clinicopathologic-characteristics-and-prognosis-of-gastric-cancer","Systematic Review and Meta-Analysis - Meta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer","","Fat mass and obesity-related gene (FTO) is aberrantly expressed across multiple cancers, including gastric cancer tissues. This meta-analysis evaluated how FTO expression relates to clinicopathological features and prognostic outcomes in gastric cancer. Literature searches in CNKI, Wanfang, VIP, CBM, PubMed, Web of Science, Cochrane Library, and EMBASE (through May 2023) followed inclusion criteria, with independent screening and NOS quality assessment using Stata.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/systematic-review-and-meta-analysis-meta-analysis-of-fto-expression-on-the-clinicopathologic-characteristics-and-prognosis-of-gastric-cancer/341922/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/systematic-review-and-meta-analysis-meta-analysis-of-fto-expression-on-the-clinicopathologic-characteristics-and-prognosis-of-gastric-cancer/341922.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the meta-analysis?","Question",{"text":63,"@type":64},"To determine how FTO expression affects clinicopathological characteristics and prognostic outcomes in gastric cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the studies searched and selected?",{"text":68,"@type":64},"Databases including CNKI, Wanfang, VIP, CBM, PubMed, Web of Science, Cochrane Library, and EMBASE were searched up to May 2023, with two researchers independently screening and extracting pathological data.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinicopathological and survival associations were found for higher FTO expression?",{"text":72,"@type":64},"Higher FTO expression correlated with TMN stage, liver metastases, and vascular invasion, and was linked to poorer overall survival and recurrence-free survival. No significant association was found with differentiation degree, age, or gender.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341922,1790499660,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","®  \nSystematic Review and Meta-Analysis   \nMeta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer  \nCiba Zhu, MMa  , Mingxu Da, MDa ,b  , Ziyao Wu, MMc , Jichun Ma, MDc , Chenglou Zhu, MDc , Xinqiao An, MMa , Dandan Ji, MMa , Chunling Xu, MDd ,*  \n\n| Abstract\u003Cbr>Background: Fat mass and obesity-related gene (FTO) is aberrantly expressed in various cancers including highly expressed in gastric cancer tissues. The aim of this meta-analysis was to explore the effect of FTO expression on clinicopathological and prognostic outcome of gastric cancer.\u003Cbr>Methods: China National Knowledge Infrastructure (CNK), Wanfang database, VIP database, Chinese biomedical literature database (CBM), PubMed, Web of Science, the Cochrane library and EMBASE database were searched to screen the literatures according to the inclusion criteria. The search time was the database establishment until May 2023. The two researchers independently searched and screened the literature, extracted pathological data, and conducted The Newcastle–Ottawa scale (NOS) quality evaluation. Analyze the correlation between FTO and pathological indicators of gastric cancer patients and the impact on prognosis, use and Stata 12.0, software for Meta-analysis.\u003Cbr>Results: A total of 1619 patients were studied in this study. The results of the Meta-analysis showed that higher expression levels of FTO were associated with TMN stage (OR = 1.83, 95% CI: 1.11–3.03, P = .019), liver metastases (OR = 3.73, 95% CI: 1.49–9.31, P = .005), vascular invasion (OR = 2.22, 95% CI: 1.36–3.61, P = .001), poorer overall survival (OS) (HR = 0.46, 95% CI: 0.34–0.58, P \u003C .001) and recurrence-free survival (HR = 0.56, 95% CI: 0.40–0.73, P \u003C .001) in gastric cancer patients. There was no significant relationship with the degree of differentiation (OR = 1.08, 95% CI: 0.49–2.35, P = .852), age (OR = 0.89, 95% CI: 0.71–1. 11, P = .306), and gender (OR = 0.92, 95% CI: 0.74–1. 14, P = .432) .\u003Cbr>Conclusion: High expression of FTO was associated with risk of distant metastases and poor prognosis for patients with gastric cancer. FTO may be a potential prognostic biomarker for gastric cancer, but due to the limited number of literature, the above results need further research.\u003Cbr>Abbreviations: DFS = disease-free survival, FTO = fat mass and obesity-associated gene, NOS = Newcastle–Ottawa Scale, OS = overall survival. |\n| --- |\n| Keywords: analysis, gastric cancer, fat mass and obesity, meta, related genes |\n\n1. Introduction  \nGastric cancer is one of the most common malignant tumors originating from the epithelial lining of the gastric mucosa in the digestive system. It predominantly presents as adenocarcinoma and ranks as the fourth leading cause of global mortality,[1,2] accounting for approximately 8% of all cancers and 10% of cancer-related deaths. The incidence rate in males is approximately twice that in females,[3] posing a significant threat to human health. Despite a declining trend in gastric cancer incidence globally in recent years, it remains highly prevalent in  \nChina, particularly in the eastern and northwestern regions, where it is among the areas with the highest incidence and mortality rates worldwide.[4] Studies have shown that gastric cancer ranks fourth and third in terms of incidence and mortality rates, respectively, among malignant tumors in China.[5,6] Gastric cancer often develops covertly, and due to the lack of early typical symptoms and screening indicators, 80% of patients are diagnosed at an advanced stage, resulting in a 5-year survival rate of less than 5% .[7] Postoperative recurrence and metastasis are the primary reasons for the low 5-year survival rate in gastric cancer.[8] Currently, clinical and pathological parameters are mainly  \nCZ and MD contributed equally to this work.  \nThe authors have no funding and conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this publ","cbCaidZl8b0OMLyL","https://ap.wps.com/l/cbCaidZl8b0OMLyL","pdf",1387593,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the goal of the meta-analysis?\",\"answer\":\"To determine how FTO expression affects clinicopathological characteristics and prognostic outcomes in gastric cancer patients.\"},{\"question\":\"How were the studies searched and selected?\",\"answer\":\"Databases including CNKI, Wanfang, VIP, CBM, PubMed, Web of Science, Cochrane Library, and EMBASE were searched up to May 2023, with two researchers independently screening and extracting pathological data.\"},{\"question\":\"What clinicopathological and survival associations were found for higher FTO expression?\",\"answer\":\"Higher FTO expression correlated with TMN stage, liver metastases, and vascular invasion, and was linked to poorer overall survival and recurrence-free survival. No significant association was found with differentiation degree, age, or gender.\"}]","Systematic Review and Meta-Analysis - Meta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer | PDF",1790044365,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f5a8b4f85e195bf5ad248af12cba9fc.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a26df8a5967a338c3636757b38476886.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/604293c398c1e236efc410f1f7a2755e.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f2269f2d0d401aae0d31be2720ddf3f.webp",980,1306]